From: Using neural networks to support high-quality evidence mapping
Class | Precision | Recall | F1 |
---|---|---|---|
Diagnosis | 0.72 (0.09) | 0.68 (0.06) | 0.70 (0.03) |
Etiology | 0.69 (0.06) | 0.50 (0.04) | 0.58 (0.04) |
Experiences and perceptions; consequences; social, political, economic aspects | 0.79 (0.08) | 0.45 (0.05) | 0.57 (0.06) |
Infection prevention and control | 0.77 (0.13) | 0.21 (0.05) | 0.33 (0.07) |
Interventions targeted at system level | 0.65 (0.21) | 0.15 (0.07) | 0.23 (0.10) |
Interventions to treat the infected patient | 0.75 (0.08) | 0.38 (0.04) | 0.50 (0.04) |
Prevalence and incidence | 0.71 (0.06) | 0.30 (0.06) | 0.42 (0.05) |
Prognosis | 0.74 (0.02) | 0.56 (0.06) | 0.63 (0.03) |